Mangifera indica L. extract (Vimang®) reduces plasma and liver cholesterol and leucocyte oxidative stress in hypercholesterolemic LDL receptor deficient mice.

Authors:
Gabriel G Dorighello
Gabriel G Dorighello
State University of Campinas
Brazil
Natalia M Inada
Natalia M Inada
São Carlos Institute of Physics
São Carlos | Brazil
Bruno A Paim
Bruno A Paim
State University of Campinas
Brazil
Anibal E Vercesi
Anibal E Vercesi
State University of Campinas
Brazil

Cell Biol Int 2018 Jun 1;42(6):747-753. Epub 2018 Mar 1.

Department of Structural and Functional Biology, Biology Institute, State University of Campinas, Campinas, São Paulo, Brazil.

Cardiovascular diseases are major causes of death worldwide. Beyond the classical cholesterol risk factor, other conditions such as oxidative stress are well documented to promote atherosclerosis. The Mangifera indica L. extract (Vimang®) was reported to present antioxidant and hypocholesterolemic properties. Thus, here we evaluate the effects of Vimang treatment on risk factors of the atherosclerosis prone model of familial hypercholesterolemia, the LDL receptor knockout mice. Mice were treated with Vimang during 2 weeks and were fed a cholesterol-enriched diet during the second week. The Vimang treated mice presented significantly reduced levels of plasma (15%) and liver (20%) cholesterol, increased plasma total antioxidant capacity (10%) and decreased reactive oxygen species (ROS) production by spleen mononuclear cells (50%), P < 0.05 for all. In spite of these benefits, the average size of aortic atherosclerotic lesions stablished in this short experimental period did not change significantly in Vimang treated mice. Therefore, in this study we demonstrated that Vimang has protective effects on systemic and tissue-specific risk factors, but it is not sufficient to promote a reduction in the initial steps of atherosclerosis development. In addition, we disclosed a new antioxidant target of Vimang, the spleen mononuclear cells that might be relevant for more advanced stages of atherosclerosis.

Download full-text PDF

Source
http://dx.doi.org/10.1002/cbin.10950DOI Listing
June 2018
4 Reads

Publication Analysis

Top Keywords

extract vimang®
8
oxidative stress
8
indica extract
8
ldl receptor
8
mangifera indica
8
factors atherosclerosis
4
capacity 10%
4
risk factors
4
treatment risk
4
atherosclerosis prone
4
prone model
4
hypercholesterolemia ldl
4
model familial
4
vimang treatment
4
antioxidant capacity
4
familial hypercholesterolemia
4
evaluate effects
4
vimang® reported
4
reported antioxidant
4
reactive oxygen
4

Similar Publications

Mangifera indica L. extract (Vimang) and its main polyphenol mangiferin prevent mitochondrial oxidative stress in atherosclerosis-prone hypercholesterolemic mouse.

Pharmacol Res 2008 May 22;57(5):332-8. Epub 2008 Mar 22.

Departamento de Investigaciones Biomédicas, Centro de Química Farmacéutica, Calle 200, Esq. 21, Playa, Ciudad de La Habana, Cuba.

Atherosclerosis is linked to a number of oxidative events ranging from low-density lipoprotein (LDL) oxidation to the increased production of intracellular reactive oxygen species (ROS). We have recently demonstrated that liver mitochondria isolated from the atherosclerosis-prone hypercholesterolemic LDL receptor knockout (LDLr(-/-)) mice have lower content of NADP(H)-linked substrates than the controls and, as consequence, higher sensitivity to oxidative stress and mitochondrial membrane permeability transition (MPT). In the present work, we show that oral supplementation with the antioxidants Mangifera indica L. Read More

View Article
May 2008

Preventing hepatocyte oxidative stress cytotoxicity with Mangifera indica L. extract (Vimang).

Drug Metabol Drug Interact 2005 ;21(1):19-29

Centro Nacional para el Control Estatal de la Calidad de los Medicamentos, Playa, Habana, Cuba.

Vimang is an aqueous extract of Mangifera indica used in Cuba to improve the quality of life in patients suffering from inflammatory diseases. In the present study we evaluated the effects of Vimang at preventing reactive oxygen species (ROS) formation and lipid peroxidation in intact isolated rat hepatocytes. Vimang at 20, 50 and 100 microg/ml inhibited hepatocyte ROS formation induced by glucose-glucose oxidase. Read More

View Article
December 2005

Mangifera indica L. extract (Vimang) and mangiferin modulate mouse humoral immune responses.

Phytother Res 2003 Dec;17(10):1182-7

Laboratorio de Farmacología, Centro de Química Farmacéutica, Ciudad de la Habana (Havana City), Cuba.

The present study investigated the effects of orally administered Vimang (an aqueous extract of Mangifera indica) and mangiferin (the major polyphenol present in Vimang) on mouse antibody responses induced by inoculation with spores of microsporidian parasites. Inoculation induced specific antibody production with an exponential timecourse, peaking after about one month. Vimang significantly inhibited this antibody production from about three weeks post-inoculation, and most markedly by four weeks post-inoculation; by contrast, mangiferin had no significant effect. Read More

View Article
December 2003

Anti-allergic properties of Mangifera indica L. extract (Vimang) and contribution of its glucosylxanthone mangiferin.

J Pharm Pharmacol 2006 Mar;58(3):385-92

Laboratory of Pharmacology, Department of Biomedical Research, Center of Pharmaceutical Chemistry, P. O. Box 16042, Havana, Cuba.

Vimang is the brand name of formulations containing an extract of Mangifera indica L., ethnopharmacologically used in Cuba for the treatment of some immunopathological disorders, including bronchial asthma, atopic dermatitis and other allergic diseases. However, the effects of Vimang on allergic response have not been reported until now. Read More

View Article
March 2006